Izeltabart (MGA021) is a humanized IgG1 monoclonal antibody targeting ADAM9, which can be used as an ADC Antibody to synthesize the ADC molecule IMGC936 (Izeltabart Tapatansine). Izeltabart can be used in the study of cancer[1].
Molecular Weight:
(147.4 kDa)
Purity:
99.91
CAS Number:
[2642078-60-0]
Target:
ADC Antibody,MMP
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted